Financhill
Back

Blueprint Medicines Stock Predictions

Blueprint Medicines Stock Forecast

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 27.6% based on the past 10 years of stock performance.
  • Blueprint Medicines has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
  • Is Blueprint Medicines Stock Undervalued?
    The current Blueprint Medicines [BPMC] share price is $129.46. The Score for BPMC is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Blueprint Medicines Stock Go Up Next Year?

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 27.6% based on the past 10 years of stock performance.

Blueprint Medicines Stock Rating

Buy
55
Blueprint Medicines (BPMC) is a Buy

Is Blueprint Medicines overpriced?

  • Blueprint Medicines has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%

Blueprint Medicines Stock Price History

Is BPMC stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
stock
Website:
blueprintmedicines.com

52-Week Data

52-Week High:
129.65
52-Week Low:
73.04

Prediction Charts

Market Cap:
8.4B
Price in USD:
129.46
Volume:
0
Beta:
0.99

Technical Analysis

SMA50:
121.81
SMA100:
105.61
SMA200:
100.61
52-Wk Change:
13.87%

Stock Predictions

  • Is Blueprint Medicines stock public?
    Yes, Blueprint Medicines is a publicly traded company.
  • What is the Blueprint Medicines stock quote today?
    The Blueprint Medicines stock price is 129.46 USD today.
  • How to buy Blueprint Medicines stock online?
    You can buy Blueprint Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jul-8 128.37 128.40 128.78 128.31
Jul-9 128.47 128.55 128.58 128.35
Jul-10 129.49 129.33 129.49 129.23
Jul-11 129.32 129.30 129.35 129.00
Jul-14 129.30 129.36 129.47 129.25
Jul-15 129.33 129.35 129.40 129.31
Jul-16 129.34 129.28 129.65 129.20
Jul-17 129.35 129.46 129.55 129.30
Jul-18 129.46 129.46 129.46 129.46
Jul-21 129.46 129.46 129.46 129.46
Jul-22 129.46 129.46 129.46 129.46
Jul-23 129.46 129.46 129.46 129.46
Jul-24 129.46 129.46 129.46 129.46
Jul-25 129.46 129.46 129.46 129.46

Blueprint Medicines Earnings

Blueprint Medicines Earnings Report: Per Share Blueprint Medicines Earnings Q1 Q2 Q3 and Q4 last year and next year.

Blueprint Medicines Forecast Revenue Growth

Blueprint Medicines Stock Analysis: Historical quarterly revenues per share for Blueprint Medicines and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.48 per share, an increase this year of $0.60 per share, and an increase next year of $1.59 per share.

* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.